Researchers reviewed studies published from 1990 through April 2026 on methods that use a light-sensitive substance and light to generate reactive oxygen species. They distinguished photodynamic inactivation, mainly used outside the body or on materials such as blood products, from photodynamic therapy, which is intended to treat infections in the body.

Of 242 records identified, 30 studies met the inclusion criteria. Most were laboratory or ex vivo studies, while 4 were animal studies and 4 were clinical studies. The review reported strong activity against enveloped viruses in laboratory testing, but emphasized that higher concentrations of the light-sensitive substances and higher light doses were generally needed for non-enveloped viruses. The clinical evidence was too limited to establish effectiveness or safety conclusively.